Taken together, this work demonstrates that MYC is upregulated by the crosstalk between ER and HER2 in AI-resistant breast cancer cells and that MYC-mediated glutamine metabolism is associated with AI resistance of breast cancer44. Here, ERBB2 is linked to breast carcinoma.